Physician profile
Alyssa Putzel
NPI 1942850409
$846.63
in general payments reported to CMS, 2019-2025
10 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4.16 · 2023: $465 · 2024: $20.06 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $197.93 | 2023-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $163.18 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Medtronic, INC. | $158.75 | 2023 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $151.32 | 2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $63.59 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $42.90 | 2025 | |
| Novo Nordisk INC | $22.14 | 2025 | |
| Phathom Pharmaceuticals, INC. | $21.98 | 2025 | Voquezna |
| Dynavax Technologies Corporation | $20.68 | 2025 | Heplisav-B |
| Genentech USA, INC. | $4.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Putzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.